The high P/S ratio of Shanghai MicroPort EP MedTech is justi...
The high P/S ratio of Shanghai MicroPort EP MedTech is justified by its superior revenue outlook. Shareholders appear confident in the company's future revenues, providing strong support to the share price. However, investment risk should always be considered.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more